logo

Humacyte Inc (HUMA) Stock: A 52-Week Tale of Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Humacyte Inc’s current trading price is -47.14% away from its 52-week high, while its distance from the 52-week low is 168.88%. The stock’s price range for this time frame has been between $1.96 and $9.97. The trading volume of the company’s shares in the Healthcare reached around 3.01 million for the day, which was evidently higher than the average daily volume of 2.67 million over the last three months.

Humacyte Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $9.97 on 05/31/24, with the lowest value being $1.96 on 11/01/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Humacyte Inc (HUMA) has experienced a quarterly rise of 68.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 627.55M and boasts a workforce of 183 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.72, with a change in price of +1.64. Similarly, Humacyte Inc recorded 2,173,508 in trading volume during the last 100 days, posting a change of +45.18%.

How HUMA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for HUMA stands at 0.71. Similarly, the long-term debt-to-equity ratio is also 0.61.

HUMA Stock Stochastic Average

Humacyte Inc’s raw stochastic average for the past 50 days is currently at 25.10%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 20.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.64% and 26.54%, respectively.

HUMA Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 85.56%.However, over the last six months, we can see a weaker performance of 97.38%. Over the last 30 days, the price of HUMA has leaped by -20.99%. And in the last five days, it has surged by 12.13%.

Most Popular